These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30068724)

  • 21. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of central venous catheter-associated thrombosis: a meta-analysis.
    Kirkpatrick A; Rathbun S; Whitsett T; Raskob G
    Am J Med; 2007 Oct; 120(10):901.e1-13. PubMed ID: 17904462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chylothorax secondary to catheter related thrombosis successfully treated with heparin.
    Siu SL; Yang JY; Hui JP; Li RC; Cheng VY; Cheung TW; Kwong AN
    J Paediatr Child Health; 2012 Mar; 48(3):E105-7. PubMed ID: 21244542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation results in increased line salvage for children with intestinal failure and central venous thrombosis.
    McLaughlin CM; Bennett M; Channabasappa N; Journeycake J; Piper HG
    J Pediatr Surg; 2018 May; 53(5):1052-1055. PubMed ID: 29499845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa.
    Parker CR; Kataria V
    AACN Adv Crit Care; 2019 Dec; 30(4):305-312. PubMed ID: 31951655
    [No Abstract]   [Full Text] [Related]  

  • 29. [Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now].
    Jansson JH
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):1984-5. PubMed ID: 16044753
    [No Abstract]   [Full Text] [Related]  

  • 30. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
    Di Minno G; Tufano A
    Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
    [No Abstract]   [Full Text] [Related]  

  • 31. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombosis and cancer.
    Kakkar AK
    Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Maintenance and care of intravascular catheters. The significance of heparinization].
    Caballero MC; Esteban BV
    Rev Enferm; 2012 Jun; 35(6):47-50. PubMed ID: 22908749
    [No Abstract]   [Full Text] [Related]  

  • 34. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of arterial thrombosis with low molecular weight heparins.
    Chesebro JH
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):26-34. PubMed ID: 9399407
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticoagulant therapy of thrombosis].
    Nakagawa M
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):959-64. PubMed ID: 9340364
    [No Abstract]   [Full Text] [Related]  

  • 38. Are patients with cancer receiving adequate thromboprophylaxis? Results from FRONTLINE.
    Wolff RA
    Cancer Treat Rev; 2003 Jun; 29 Suppl 2():7-9. PubMed ID: 12887943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparins for arterial thrombosis.
    Nenci GG; Minciotti A
    Vasc Med; 2000; 5(4):251-8. PubMed ID: 11213238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.